Share

From A Distance: The Endocrine Society’s Newest Perspective Statement on Telehealth Encourages Individualized Care

october 2022 cover This month, The Journal of Clinical Endocrinology & Metabolism is publishing “Appropriate Use of Telehealth Visits in Endocrinology: Perspective Statement of the Endocrine Society.” Since this new modality is here to stay, Endocrine News talks to the authors about which patients are better candidates for telehealth than others, why endocrinology seems tailor-made for this new...
Share

Endocrine Society Experts Recommend Individualized Approach to Use of Telehealth  

Policy perspective explores factors to maximize effectiveness of telehealth Following rapid growth during the COVID-19 pandemic, telehealth visits are expected to remain an important part of endocrine care, according to a new Endocrine Society policy perspective published in The Journal of Clinical Endocrinology & Metabolism.   Health care providers need to consider a variety of...
Share

Positive Clinical Data for Oral Treatment of Acromegaly Presented at ENDO

ENDO 2022 saw the presentation of positive clinical data from the open-label extensions (OLEs) of two of the Phase 3 trials of oral octreotide for patients with acromegaly. Amryt is marketing the drug as Mycapssa. Data presented in a late-breaking poster presentation of the 2nd year of the OLE of OPTIMAL (NCT03252353), a randomized, double-blind...
Share

FDA Approves Spinal Cord Stimulation Therapy for Treating Chronic Pain Resulting from Diabetic Peripheral Neuropathy

The U.S. Food and Drug Administration (FDA) last month approved a rechargeable neurostimulator and a recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). Medtronic is marketing the products as Intellis™ and Vanta™, respectively. DPN is a debilitating and progressive neurological disorder that affects approximately 30% of people with diabetes,...
Share

2021 Progress Report: Part 1

december 2021 cover Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new treatments for acromegaly, thyroid eye disease, hypoglycemia, and diabetes to new devices aimed at glucose monitoring in adults and children, a mail-in semen analysis kit, and much more, Endocrine News takes a closer...
Share

Evolution of Diabetes Management: The Patient-Provider Relationship, Accessing Resources, and Surmounting Obstacles

100_Years_of_Insulin_Logo During insulin’s first century, treatments and resources for people with diabetes have steadily progressed. So, too, have relationships between the patient and the provider. A recent Endocrine Society-hosted roundtable highlighted this vital connection and how it has evolved through the decades. Leonard Thompson was 14 years old in 1922, and he was dying of type...
Share

Rare But Devastating: Keeping Track of Acromegaly Cases

Since acromegaly is such a rare disorder, when an endocrinologist is presented with a potential case, the most accurate and complete data available would be a helpful tool. Endocrine News takes a closer look at how the Mexican Acromegaly Registry has helped endocrinologists address the issues patients with acromegaly face, both physically and financially.  ...
Show More